Despite the abundant diseases caused by rhabdoviruses on plants, animals and men, there are no approved therapeutic drugs. This work targeted viral hemorrhagic septicemia viruses (VHSV), a group of representative rhabdoviruses causing devastating world-wide diseases on fish farmed-species. In particular, their glycoprotein (gpGVHSV) trimers were computationally targeted at its earliest pre-fusion inner interface. Co-evolution initiated from an optimized 2D-molecular parent and the corresponding gpGVHSV -conformer 3D cavity, generated tens of thousands of raw-children, and selected hundreds of cross-fitting conformer variations in a few scaffolds. Their predicted drug-like high affinities in nanoMolar ranges, low toxicities and targeting the pre-fusion inner interface were confirmed by independent algorithms